Page last updated: 2024-09-05

migalastat and Adverse Drug Event

migalastat has been researched along with Adverse Drug Event in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Capuano, I; Cocozza, S; Feriozzi, S; Ferreri, L; Imbriaco, M; Pisani, A; Riccio, E; Santoro, C; Zanfardino, M	1

Other Studies

1 other study(ies) available for migalastat and Adverse Drug Event

Article	Year
Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data. European journal of human genetics : EJHG, 2020, Volume: 28, Issue:12 Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Aged; alpha-Galactosidase; Drug Administration Schedule; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Enzyme Replacement Therapy; Fabry Disease; Humans; Isoenzymes; Male; Middle Aged; Recombinant Proteins	2020

Article

Year

Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data.

European journal of human genetics : EJHG, 2020, Volume: 28, Issue:12

Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Aged; alpha-Galactosidase; Drug Administration Schedule; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Enzyme Replacement Therapy; Fabry Disease; Humans; Isoenzymes; Male; Middle Aged; Recombinant Proteins

2020